Evotec acquires Cell Culture Service GmbH
Evotec announced the acquisition of all shares in Cell Culture Service GmbH (CCS), a Hamburg-based company which supports the cell culture needs of a customer base of biotech and Pharmaceutical companies. CCS is supplier of custom cells and cell-based reagents such as recombinant assay cell lines, assay-ready Frozen Instant Cells, membranes, and proteins for high throughput screening.
'Through the acquisition of CCS, Evotec strengthens its cell culture capabilities and gains access to a growing base of customers using cell-based assays in their drug discovery processes. CCS' experience and technologies for large scale cell production are a perfect fit with Evotec's screening and in vitro pharmacology activities', said Dr Mario Polywka, Chief Operating Officer of Evotec AG.
Other news from the department business & finance
